Cellectar Biosciences Inc (NASDAQ: CLRB) is -44.77% lower on its value in year-to-date trading and has touched a low of $1.38 and a high of $4.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CLRB stock was last observed hovering at around $1.56 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $1.53, the stock is -18.20% and -23.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing -1.92% at the moment leaves the stock -43.45% off its SMA200. CLRB registered -31.39% loss for a year compared to 6-month loss of -49.67%. The firm has a 50-day simple moving average (SMA 50) of $2.0038 and a 200-day simple moving average (SMA200) of $2.7151.
The stock witnessed a -25.37% gain in the last 1 month and extending the period to 3 months gives it a -30.14%, and is -1.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.88% over the week and 6.93% over the month.
Cellectar Biosciences Inc (CLRB) has around 23 employees, a market worth around $63.14M and $0.00M in sales. Distance from 52-week low is 10.47% and -65.62% from its 52-week high. The company has generated returns on investments over the last 12 months (-295.11%).
The EPS is expected to grow by 51.88% this year
39.0 institutions hold shares in Cellectar Biosciences Inc (CLRB), with institutional investors hold 35.56% of the company’s shares. The shares outstanding are 41.27M, and float is at 40.02M with Short Float at 2.90%. Institutions hold 34.55% of the Float.
